Banque Transatlantique Sa Bio N Tech Se Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
A detailed history of Banque Transatlantique Sa transactions in Bio N Tech Se stock. As of the latest transaction made, Banque Transatlantique Sa holds 954 shares of BNTX stock, worth $94,140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
954Holding current value
$94,140% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
340Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$805 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$420 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$399 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$187 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$178 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $23.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...